News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER Research Update: March 2026
Recent RECOVER publications include findings about possible causes of and treatments for Long COVID.
Feature
157 Results
157 Results
R3 Seminar Recap: Long COVID after SARS-CoV-2 during pregnancy
During a recent RECOVER Research Review (R3) seminar, RECOVER researchers Torri Metz, MD, MS, Chengxi Zang, PhD, and Valerie Flaherman, MD, MPH, shared findings from two major studies examining the risk of developing Long COVID following a SARS-CoV-2 infection during pregnancy. Drawing on data from RECOVER’s observational study of pregnant women and from two national electronic health record (EHR) research networks, these studies represent some of the largest efforts to date exploring the relationship between pregnancy and Long COVID.
R3 Seminar Recap
RECOVER pathobiology studies look inside the body to learn more about Long COVID
RECOVER is funding 60+ pathobiology studies to explore how cells in the body interact with each other to cause Long COVID symptoms. These findings may lead to better ways to diagnose, treat, and prevent Long COVID.
Feature
RECOVER Research Update: June 2025
By studying millions of patients’ electronic health records (EHRs), RECOVER researchers are gaining understanding about who Long COVID affects, how it affects them, and why some people are more likely to be affected than others.
Research Update
RECOVER study provides new insights on the relationship between pregnancy and Long COVID
Recent RECOVER findings provide insights into how changes to the immune system during pregnancy may affect a woman’s risk of developing Long COVID.
Feature
RECOVER EHR study provides additional information about pediatric Long COVID symptoms
Researchers identified six common groups of symptoms experienced by children and adolescents with Long COVID.
Feature
RECOVER researchers develop new tools to help identify Long COVID in youngest children
Researchers analyzed data from RECOVER’s pediatric observational study to better understand how Long COVID impacts infants, toddlers, and preschool-aged children.
Feature
RECOVER study identifies unique symptom patterns of Long COVID in young children
Findings from a recent RECOVER pediatric observational study show that the most common Long COVID symptoms experienced by children 0 to 5 years old can be different than those experienced by older children and adults.
News Release
R3 Seminar Recap: Understanding metformin use and Long COVID and ME/CFS following COVID-19 infection: Insights from two studies
A recent RECOVER Research Review (R3) Seminar held May 13 spotlighted research presented by Carolyn Bramante, MD, MPH (University of Minnesota) and Steve Johnson, PhD (University of Minnesota) exploring how metformin, a widely prescribed medication primarily used to manage type 2 diabetes, may help reduce the risk of Long COVID. The seminar also featured a presentation from Suzanne Vernon, PhD (Bateman Horne Center) on research examining the risk of developing myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) following a COVID-19 infection.
R3 Seminar Recap